These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 30806742

  • 1. Combination therapy of transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) for small hepatocellular carcinoma: comparison with TACE or RFA monotherapy.
    Kim W, Cho SK, Shin SW, Hyun D, Lee MW, Rhim H.
    Abdom Radiol (NY); 2019 Jun; 44(6):2283-2292. PubMed ID: 30806742
    [Abstract] [Full Text] [Related]

  • 2. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
    Hyun D, Cho SK, Shin SW, Park KB, Park HS, Choo SW, Do YS, Choo IW, Lee MW, Rhim H, Lim HK.
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progression.
    Cao S, Zou Y, Lyu T, Fan Z, Guan H, Song L, Tong X, Wang J.
    Int J Hyperthermia; 2022 Mar; 39(1):1-7. PubMed ID: 34937501
    [Abstract] [Full Text] [Related]

  • 4. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
    Hyun D, Cho SK, Shin SW, Park KB, Lee SY, Park HS, Do YS.
    Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
    [Abstract] [Full Text] [Related]

  • 5. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z, Wei M, Chen S, Lin M, Jiang C, Mei J, Li B, Wang Y, Li J, Xie X, Kuang M.
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [Abstract] [Full Text] [Related]

  • 6. Transarterial Chemoembolization Monotherapy in Combination with Radiofrequency Ablation or Percutaneous Ethanol Injection for Hepatocellular Carcinoma.
    Xu C, Lv PH, Huang XE, Wang SX, Sun L, Wang FA.
    Asian Pac J Cancer Prev; 2016 Aug; 17(9):4349-4352. PubMed ID: 27797242
    [Abstract] [Full Text] [Related]

  • 7. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Song Q, Ren W, Fan L, Zhao M, Mao L, Jiang S, Zhao C, Cui Y.
    Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995
    [Abstract] [Full Text] [Related]

  • 8. Combination of radiofrequency ablation with transarterial chemoembolization for treatment of hepatocellular carcinoma: experience from a Danish tertiary liver center.
    Bharadwaz A, Bak-Fredslund KP, Villadsen GE, Nielsen JE, Simonsen K, Sandahl TD, Grønbæk H, Nielsen DT.
    Acta Radiol; 2016 Jul; 57(7):844-51. PubMed ID: 26342009
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK.
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [Abstract] [Full Text] [Related]

  • 12. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
    Ni JY, Liu SS, Xu LF, Sun HL, Chen YT.
    World J Gastroenterol; 2013 Jun 28; 19(24):3872-82. PubMed ID: 23840128
    [Abstract] [Full Text] [Related]

  • 13. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.
    J Gastroenterol Hepatol; 2016 Feb 28; 31(2):442-9. PubMed ID: 26259976
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma.
    Chen L, Kan X, Sun T, Ren Y, Cao Y, Yan L, Liang B, Xiong B, Zheng C.
    BMC Gastroenterol; 2020 Jun 29; 20(1):205. PubMed ID: 32600349
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Medium or Large Hepatocellular Carcinoma: Sorafenib Combined with Transarterial Chemoembolization and Radiofrequency Ablation.
    Zhu K, Huang J, Lai L, Huang W, Cai M, Zhou J, Guo Y, Chen J.
    Radiology; 2018 Jul 29; 288(1):300-307. PubMed ID: 29688153
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L, Tian J, Liu P, Wang X, Zhu Z.
    Tumori; 2016 Jun 02; 2016(3):301-10. PubMed ID: 27002950
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe.
    Lee BC, Liu KL, Wu CH, Huang KW, Ho CM, Hu RH, Ho MC, Wu YM, Lee PH, Liang PC.
    Cardiovasc Intervent Radiol; 2018 Nov 02; 41(11):1699-1707. PubMed ID: 29946941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.